Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-044548
Filing Date
2024-10-29
Accepted
2024-10-29 17:05:38
Documents
1
Period of Report
2024-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3646
  Complete submission text file 0001140361-24-044548.txt   5225
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10116
Business Address
Bjork Elisabeth (Reporting) CIK: 0001810406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 241406574